The closing price of Physicians Realty Trust (NYSE: DOC) was $14.85 for the day, up 0.81% from the previous closing price of $14.73. In other words, the price has increased by $+0.12 from its previous closing price. On the day, 2128916 shares were traded. DOC stock price reached its highest trading level at $15.05 during the session, while it also had its lowest trading level at $14.67.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Our analysis of DOC’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 469.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 397.67. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.63.
Upgrades & Downgrades
On October 28, 2022, JP Morgan started tracking the stock assigning a Neutral rating and target price of $17.
Colliers Securities Downgraded its Buy to Neutral on August 05, 2022, while the target price for the stock was maintained at $19.
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 28 when BLACK ALBERT JR bought 1,021 shares for $14.98 per share. The transaction valued at 15,295 led to the insider holds 99,208 shares of the business.
Thompson Tommy G bought 6,575 shares of DOC for $98,888 on Dec 14. The Director now owns 25,635 shares after completing the transaction at $15.04 per share. On Dec 13, another insider, Thompson Tommy G, who serves as the Director of the company, bought 17,760 shares for $15.16 each. As a result, the insider paid 269,242 and bolstered with 19,060 shares of the company.
As of this moment, Physicians’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.49, and their Forward P/E ratio for the next fiscal year is 63.19. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.35. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.87 while its Price-to-Book (P/B) ratio in mrq is 1.19.
Stock Price History:
Over the past 52 weeks, DOC has reached a high of $18.83, while it has fallen to a 52-week low of $13.42. The 50-Day Moving Average of the stock is 15.22, while the 200-Day Moving Average is calculated to be 15.83.
DOC traded an average of 1.95M shares per day over the past three months and 2.32M shares per day over the past ten days. A total of 229.16M shares are outstanding, with a floating share count of 226.19M. Insiders hold about 0.20% of the company’s shares, while institutions hold 96.10% stake in the company. Shares short for DOC as of Jan 30, 2023 were 9.02M with a Short Ratio of 9.39M, compared to 9.83M on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.95% and a Short% of Float of 5.59%.
Dividends & Splits
With its trailing 12-month dividend rate of 0.92, DOC has a forward annual dividend rate of 0.92. Against a Trailing Annual Dividend Yield of 6.25%, it implies a Forward Annual Dividend Yield of 6.01%. The stock’s 5-year Average Dividend Yield is 5.36.
The firm’s stock currently is rated by 6 analysts. On average, analysts expect EPS of $0.04 for the current quarter, with a high estimate of $0.05 and a low estimate of $0.03, while EPS last year was $0.12. The consensus estimate for the next quarter is $0.04, with high estimates of $0.05 and low estimates of $0.03.
Analysts are recommending an EPS of between $0.44 and $0.42 for the fiscal current year, implying an average EPS of $0.43. EPS for the following year is $0.18, with 8 analysts recommending between $0.23 and $0.12.
It is expected that $90B in revenue will be generated in the current quarter, according to 6 analysts. It ranges from a high estimate of $133.8M to a low estimate of $127.37M. As of the current estimate, Physicians Realty Trust’s year-ago sales were $116.12M, an estimated increase of 12.80% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $130.78M, an increase of 0.30% less than the figure of $12.80% in the same quarter last year. There is a high estimate of $135.6M for the next quarter, whereas the lowest estimate is $124.5M.
A total of 8 analysts have provided revenue estimates for DOC’s current fiscal year. The highest revenue estimate was $528M, while the lowest revenue estimate was $509.15M, resulting in an average revenue estimate of $522.59M. In the same quarter a year ago, actual revenue was $457.7M, up 14.20% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $535.19M in the next fiscal year. The high estimate is $559.62M and the low estimate is $501.17M. The average revenue growth estimate for next year is up 2.40% from the average revenue estimate for this year.